Effects of interferon treatment on the glucose metabolism of patients with chronic hepatitis C

European Journal of Internal Medicine

Volumn 11, Issue 3, 2000, Pages 151-155

  Nemesánszky, Elemér ^a   Pusztay, Margit ^a   Csepregi, Antal ^a  

^a Polyclinic of the Hospitaller Brothers of St John of God ^*  (Hungary)

Author keywords

Chronic hepatitis; Diabetes mellitus; Hepatitis C; Interferon

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HEPATITIS C; HUMAN; MALE;

EID: 18144448740     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00080-7     Document Type: Article

References (23)

1. Feingold K.R., Grunfeld C. Role of cytokines in inducing hyperlipidaemia. Diabetes. 41:(Suppl. 2):1992;97-101.
2. Gervain J., Goógl A. Side effects of interferon-alpha treatment in patients with chronic hepatitis. 10th International Congress of Liver Diseases, Basel: 19-21 October 1995;106. Abstracts.
3. Giuntoli P., Mariani S., Avoli D., Giammarco V. Insulin dependent diabetes mellitus induced by interferon-alpha. Minerva Endocrinol. 20:1995;243-245.
4. Pár A. Krónikus C hepatitis: virológiai, immunológiai sajátosságok és a terápia kérdései. Orv Hetil. 138:1997;1465. in Hungarian.
5. Campbell S., McLaren E.H., Danesh B.J. Rapidly reversible increase in insulin requirement with interferon. Br. Med. J. 3:1996;313-314.
6. Gross U., Seifert E. Transient insulin dependent diabetes mellitus with alpha-interferon therapy in chronic active hepatitis. Z Gastroenterol. 31:1993;609-611.
7. Imagawa A., Itoh N., Hanfusa T., et al. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab. 80:1995;922-926.
8. Waguri M., Hanafusa T., Itoh N., et al. Occurrence of IDDM during interferon therapy for chronic viral hepatitis. Diabetes Res Clin Pract. 23:1994;33-36.
9. Whitehead R.P., Hauschild A., Christophers E., et al. Diabetes mellitus in cancer patients treated with combination interleukin 2 and alpha-interferon. Cancer-Biother. 10:1995;45-51.
10. Brouhard B.H. Cytokines and the pathogenesis of insulin-dependent diabetes mellitus. Cleve Clin. J. Med. 59:1992;629-633.
11. Herold K.C., Vezis V., Sun Q., et al. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol. 156:1996;3521-3527.
12. Hultgren B., Huang X., Dybdal N., et al. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 45:1996;812-817.
13. Janjic D., Asfari M. Effects of cytokines on rat insulinoma INS-1 cells. J Endocrinol. 132:1992;67-76.
14. Stewart T.A., Hultgren B., Huang X., et al. Induction of type I diabetes by interferon-alpha in transgenic mice. Science. 25:1993;1942-1946.
15. Sobel D.O., Ewel C.H., Zeligs B., et al. Induction of alpha-interferon in the diabetes prone BB and normal Wistar rats. Diabetes. 43:1994;518-522.
16. Vial T., Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology. 105:1995;31-57.
17. Cetkovic L., Cvrlje M., Eizirik D.L. TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine. 6:1994;399-406.
18. Krug J., Fritzsch J., Aust G. Induction of insulin antibodies and insulin allergy under alpha-interferon treatment of renal cell carcinoma in a patient with insulin treated diabetes mellitus - a case report. Int Arch Allergy Immunol. 106:1995;169-172.
19. Gatzen C.M., Manfras B.J., Wiest U. Insulin-dependent diabetes mellitus due to interferon alpha-2 - a therapy for chronic viral hepatitis C. Digestive Disease Week, New Orleans, LA: 17-20 May 1998;117. Abstracts.
20. Bonnevie-Nielsen V., Buschard K., Dyrberg T. Differential responsiveness to interferon-alpha in beta-cells and non-beta cells. Diabetes. 45:1996;818-821.
21. Huang X., Yuang J., Goddard A., et al. Interferon expression in the pancreas of patients with type I diabetes. Diabetes. 44:1995;658-664.
22. Mangia A., Schiavone G., Lezzi G., et al. HCV and diabetes mellitus: evidence for a negative association. Am J. Gastroenterol. 93:1998;2363-2367.
23. Zein N.N. Hepatitis C and diabetes mellitus: an ongoing controversy. Am. J. Gastroenterol. 93:1998;2320-2321.